Central insulin dysregulation and energy dyshomeostasis in two mouse models of Alzheimer's disease
Open accessThe DOI matches its Crossref record; 26 of the 26 references it cites were found in a registry or an index.
Abstract
Alzheimer’s disease (AD) is the most prevalent neurodegenerative disorder worldwide. While the causes of AD are not known, several risk factors have been identified. Among these, type 2 diabetes (T2D), a chronic metabolic disease, is one of the most prevalent risk factors for AD. Insulin resistance, which is associated with T2D, is defined as diminished or absent insulin signaling, and is reflected by peripheral blood hyperglycemia and impaired glucose clearance. In this study, we used complimentary approaches to probe for peripheral insulin resistance, central nervous system (CNS) insulin sensitivity and energy homeostasis in Tg2576 and 3xTg-AD mice, two widely used animal models of AD. We report that CNS insulin signaling abnormalities are evident months before peripheral insulin resistance. Additionally, we find that brain energy metabolism is differentially altered in both mouse models, with the 3xTg-AD mice showing more extensive changes. Collectively, our data suggest that early AD may reflect engagement of different signaling networks that influence CNS metabolism, which in-turn may alter peripheral insulin signaling.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Mechanisms linking obesity to insulin resistance and type 2 diabetes
Kahn, S. E., Hull, R. L., & Utzschneider, K. M. (2006) · Nature · doi:10.1038/nature05482 · Cited by 5,448 · cited 2×
“Peripheral insulin resistance is often associated with increased body weight and obesity (Kahn et al., 2006).”
BackgroundResult2016 Alzheimer's disease facts and figures
Alzheimer's Association (2016) · Alzheimer's & Dementia · doi:10.1016/j.jalz.2016.03.001 · Cited by 5,069
Querfurth, H. W., & LaFerla, F. M. (2010) · New England Journal of Medicine · doi:10.1056/nejmra0909142 · Cited by 4,569
Talbot, K., Wang, H.-Y., Kazi, H., Han, L.-Y., Bakshi, K. P., Stucky, A., Fuino, R. L., Kawaguchi, K. R., Samoyedny, A. J., Wilson, R. S., et al. (2012) · Journal of Clinical Investigation · doi:10.1172/jci59903 · Cited by 1,871 · cited 10×
“The insulin receptor (IR), the insulin receptor substrate-1 (IRS-1), the phosphoinositide-dependent kinase-1 (PDK1), and the alpha serine/threonineprotein kinase (AKT) are regulated through stoichiometric activation/inactivation phosphorylation profiles and form the components of a highly integrated intracellular insu…”
BackgroundResultInfluentialSteen, E., Terry, B. M., J. Rivera, E., Cannon, J. L., Neely, T. R., Tavares, R., Xu, X. J., Wands, J. R., & de la Monte, S. M. (2005) · Journal of Alzheimer's Disease · doi:10.3233/jad-2005-7107 · Cited by 1,703 · cited 5×
“The insulin receptor (IR), the insulin receptor substrate-1 (IRS-1), the phosphoinositide-dependent kinase-1 (PDK1), and the alpha serine/threonineprotein kinase (AKT) are regulated through stoichiometric activation/inactivation phosphorylation profiles and form the components of a highly integrated intracellular insu…”
BackgroundInfluentialAmyloid deposition precedes tangle formation in a triple transgenic model of Alzheimer's disease
Oddo, S. (2003) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2003.08.012 · Cited by 980 · cited 6×
“Given that the 3xTg-AD mice develop NFTs, this suggests that AMPK upregulation may contribute to or even be a consequence of the tau pathology unique to this model (Oddo et al., 2003).”
BackgroundMethodInfluentialSelf-citationIncreased Risk of Type 2 Diabetes in Alzheimer Disease
Janson, J., Laedtke, T., Parisi, J. E., O’Brien, P., Petersen, R. C., & Butler, P. C. (2004) · Diabetes · doi:10.2337/diabetes.53.2.474 · Cited by 950 · cited 1×
“Epidemiological, clinical, and preclinical, evidence compellingly suggests that T2D and AD bear interrelated disease risks and mechanisms (Haan, 2006; Heneka et al., 2015; Janson et al., 2004; Kandimalla et al., 2016; Steen et al., 2005).”
BackgroundPositive and negative regulation of insulin signaling through IRS-1 phosphorylation
Gual, P., Le Marchand-Brustel, Y., & Tanti, J.-F. (2005) · Biochimie · doi:10.1016/j.biochi.2004.10.019 · Cited by 912 · cited 8×
“The insulin receptor (IR), the insulin receptor substrate-1 (IRS-1), the phosphoinositide-dependent kinase-1 (PDK1), and the alpha serine/threonineprotein kinase (AKT) are regulated through stoichiometric activation/inactivation phosphorylation profiles and form the components of a highly integrated intracellular insu…”
BackgroundInfluentialAMPK signalling in health and disease
Carling, D. (2017) · Current Opinion in Cell Biology · doi:10.1016/j.ceb.2017.01.005 · Cited by 797 · cited 1×
“Energy homeostasis is an additional dimension to the cellular and physiological dysfunction related to insulin resistance and T2D (Carling, 2017; Porte, 2006; Saha et al., 2010).”
BackgroundInsulin signaling in health and disease
White, M. F. (2003) · Science · doi:10.1126/science.1092952 · Cited by 733 · cited 1×
“…of the PDK1/AKT pathways, induces glycogen synthesis through the target of rapamycin complexes to control AMP-activated protein kinase (AMPK), energy metabolism, mitochondrial function, synaptic plasticity and memory (Cheng et al., 2010; Kleinridders et al., 2014; Stoica et al., 2011; White, 2003).”
Background
Cited by
Type 3 Diabetes and Its Role Implications in Alzheimer’s Disease
Nguyen, T. T., Ta, Q. T. H., Nguyen, T. K. O., Nguyen, T. T. D., & Van Giau, V. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21093165 · Cited by 393
Salameh, T. S., Rhea, E. M., Talbot, K., & Banks, W. A. (2020) · Biochemical Pharmacology · doi:10.1016/j.bcp.2020.114187 · Cited by 188
“Brain insulin resistance, which can be induced by systemic insulin resistance [19-23] or independently by brain Aβ oligomers and hyperphosphorylated tau [24], promotes many AD-like [22, 25-27] and PD-like [16, 28, 29] pathologies.”
BackgroundVelazquez, R., Ferreira, E., Knowles, S., Fux, C., Rodin, A., Winslow, W., & Oddo, S. (2019) · Aging Cell · doi:10.1111/acel.13037 · Cited by 156
Self-citationCognitive dysfunction: a growing link between diabetes and Alzheimer’s disease
Jash, K., Gondaliya, P., Kirave, P., Kulkarni, B., Sunkaria, A., & Kalia, K. (2020) · Drug Development Research · doi:10.1002/ddr.21579 · Cited by 119
Rhea, E. M., Babin, A., Thomas, P., Omer, M., Weaver, R., Hansen, K., Banks, W. A., & Talbot, K. (2024) · Tissue Barriers · doi:10.1080/21688370.2023.2292461 · Cited by 81
Metadata
- Authors
- Velazquez, R., Tran, A., Ishimwe, E., Denner, L., Dave, N., Oddo, S., & Dineley, K. T.
- Venue
- Neurobiology of Aging
- Publisher
- Elsevier BV
- Published
- 2017-10
- Volume
- 58
- Pages
- 1-13
- ISSN
- 0197-4580 (ISSN-L)
- OpenAlex
- W2651360079
- Cited by
- 90
- References
- 26
- FWCI
- 6.70
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Central insulin dysregulation and energy dyshomeostasis in two mouse models of Alzheimer's disease. https://app.cochat.ai/papers/10.1016/j.neurobiolaging.2017.06.003
- The paper
- Velazquez, R., Tran, A., Ishimwe, E., Denner, L., Dave, N., Oddo, S., & Dineley, K. T. (2017). Central insulin dysregulation and energy dyshomeostasis in two mouse models of Alzheimer's disease. Neurobiology of Aging. https://doi.org/10.1016/j.neurobiolaging.2017.06.003
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.